Source: BioPortfolio

DalCor Pharmaceuticals: DalCor Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250

SummaryDalCor Pharmaceuticals Inc DalCor Pharmaceuticals researches and develops precision medicine for patients suffering from cardiovascular diseases. The company is engaged in development of Dalcetrapib a cholesterol ester transfer protein CETP inhibito...

Read full article »
DalCor Pharmaceuticals's Competitors | DalCor Pharmaceuticals's News | DalCor Pharmaceuticals's Financials
Stay up-to-date with the latest news on DalCor
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Fouzia Laghrissi-Thode's photo - CEO of DalCor

CEO

Fouzia Laghrissi-Thode

CEO Approval Rating

87/100

Read more
Stay up-to-date with the latest news on DalCor